Dr. Brian Chen's research has examined the tradeoffs between moral hazard and efficiencies in the integration of physician and non-physician medical services in the presence of asymmetric information. He has looked at a policy intervention in Taiwan that prohibited self-referrals of patients to physician-owned pharmacies unless the physician group integrated pharmacy services into the clinic by hiring an onsite pharmacist. He found that the policy reduced drug expenditures by close to thirty percent among physicians that did not have an onsite pharmacist. However, these physicians responded by increasing the overprovision of diagnostic services not covered by the policy, thereby reducing the effectiveness of the policy. Forty-five percent of the clinics that did not have an onsite pharmacist prior to the policy hired one subsequent to the implementation of the policy. Overall, after integration, the policy applied to only seventeen percent of clinics, and only reduced average discretionary expenditures by about two-point-five percent. Chen's research also shows that despite the reduction in drug utilization, patients treated at clinics without an onsite pharmacist did not have greater observable adverse health events than patients treated at integrated clinics. His results show that moral hazard costs of self-referral incentives are large, that the “safe harbor” exemption severely reduces the effectiveness of the policy, and that the exemption explains much of the recent integration of ancillary services into physician offices.

Dr. Brian Chen recently completed his Ph.D. in business administration in the Business and Public Policy Group at the Haas School of Business, University of California at Berkeley. He received a Juris Doctor from Stanford Law School in 1997, and graduated summa cum laude from Harvard College in 1992.

On January 1, 2010, China and the ten-member Association of Southeast Asian Nations (ASEAN) finally, formally launched a China-ASEAN Free Trade Agreement (CAFTA) that encompasses nearly two billion people engaged in trade worth some $200 billion. For China the agreement is a way of securing supplies of raw materials, while the ASEAN countries hope the agreement will open opportunities in China's huge domestic market. When CAFTA  was first signed in November 2002, Beijing promised that Southeast Asia would reap an “early harvest” of its benefits. Yet the Southeast Asian response to CAFTA in the agreement’s first year has been less than enthusiastic, especially in the Philippines and Indonesia. Is CAFTA a bonanza? A blunder? Something in between? Prof. Mendoza will assess the agreement, its implementation, and the implications for China’s role and image in Southeast Asia going forward.

Amado M. Mendoza, Jr. is a leading policy scholar in the Philippines, where he also serves as the treasurer of Economic, Social, and Cultural Rights (ESCR) Asia, Inc., an NGO dedicated to the promotion of socio-economic and cultural rights. He is the Philippines’ lead contributor to the soon-to-be-released 2010 Global Integrity Report on governance and corruption. Other subjects of his current research include Asian regional integration; Asian summitry and economic crisis management; Philippine economic diplomacy; and China-Taiwan relations within a regional context. In addition to his academic career, he has a background in journalism, banking, and development.

In this special seminar event, Dr. Szu-yin Ho will examine the current Taiwan-China relations within the framework of international relations theory. He will elaborate how both sides of the Taiwan Strait perceive this relationship, what the implications for the building of new institutions are after President Ma Ying-jeou took office, and what kind of signals these new institutions have delivered. Dr. Ho will also give his concerns and predictions about the future relationship across the Taiwan Strait. In this special seminar, Professor Wei-chin Lee from Wake Forest University will comment on Dr. Ho's speech.

Szu-yin Ho is Professor of Political Science at the National Chengchi University. He received his BA degree (1978) in English Literature from National Taiwan University, MA (1983) and Ph.D. (1986) in Political Science from the University of California at Santa Barbara. After receiving doctoral degree, Professor Ho first joined the Academia Sinica, then moved to the Institute of International Relations, National Chengchi University, Taipei, Taiwan. He later served as the Deputy Director of the Institute from 1994 to 1999 and the Director from 1999-2003. From 2003 to 2008 he served as the Director of International Affairs of the KMT, Taiwan's current ruling party. After the presidential election in 2008, he moved to become the Deputy Secretary-General of the National Security Council in the Presidential Office, overseeing the country's foreign affairs. After two years of service in government, Mr. Ho went back to academia. Professor Ho specializes on international relations, comparative political economy, sampling survey, and Chinese politics. He had published books and articles, in both Chinese and English, along these lines of research.

Wei-chin Lee received his Ph.D. in Political Science from University of Oregon. He is Professor of Political Science at Wake Forest University in North Carolina. He has published several books, including the latest edited volume on Taiwan's Politics in the 21th Century (2010). His articles have appeared in various scholarly journals. His teaching and research interests include foreign policy and domestic politics of China and Taiwan, US policy toward East Asia, international security, and international institutions. He is currently serving as an advisor to the Taiwan Benevolent Association of America.

This is a special event cosponsored by CDDRL and Taiwan Benevolent Association of  America.

Asian Biotech:  Ethics and Communities of Fate is the title of a new book that Prof. Ong has co-edited with Nancy N. Chen.  It offers the first overview of Asia’s emerging initiatives in the biosciences.  Its case studies include blood collection in Singapore and China; stem-cell research in Singapore, South Korea, and Taiwan; genetically modified foods in China; and clinical trials in India.  Such projects vary by country, as do the policies that are associated with them.  Discernible nevertheless is a significant trend toward state entrepreneurialism in Asian biotechnology.  Prof. Ong will also explore how political thinking and ethical reasoning are converging around the biosciences in Asia.  Copies of Asian Biotech will be available for signing and purchase at the talk.

Aihwa Ong studies how the interactions of capitalism, technology, politics, and ethics crystallize global situations, frame spaces of problematization, and generate situated solutions.  With these matters in mind, she has done field research in Southeast Asia, Southern China, and California.  A forthcoming volume is Worlding Cities:  Asian Experiments and the Art of Being Global.  Prior publications include Spirits of Resistance and Capitalist Discipline (2nd ed., 2010); Privatizing China:  Socialism from Afar (co-edited, 2008); Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems (co-edited, 2005); Flexible Citizenship:  The Cultural Logics of Transnationality (1999); Neoliberalism as Exception:  Mutations in Citizenshipand Sovereignty (2006); and Buddha is Hiding:  Refugees, Citizenship, the New America (2003).  Prof. Ong has received many awards and has lectured at universities around the world.  She chairs of the US National Committee for the Pacific Science Association.  Her 1982 PhD is from Columbia University.